November 2025
1. COOPER ME, van Raalte DH
   GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity.
   J Clin Invest. 2025;135:e194749.
   

   >> Share

   
   May 2025
2. JALAL DI, Thurman JM, Smith RJ
   Chronic kidney disease enhances alternative pathway activity: a new paradigm.
   J Clin Invest. 2025;135:e188353.
   

   >> Share

   
   February 2025
3. LI Y, Ma C, Sheng Y, Huang S, et al
   TRIB3 mediates vascular calcification through facilitating self-ubiquitination and dissociation of Smurf1 in chronic renal disease.
   J Clin Invest. 2025 Feb 11:e175972. doi: 10.1172/JCI175972.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share